Alphagan and Colcrys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan (brimonidine tartrate) and Colcrys (colchicine). Common drug interactions include chronic kidney disease among females and eye infection among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan and Colcrys. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.

On Jul, 20, 2026

14 people who take Alphagan and Colcrys together, and have interactions are studied.

What are the common drug interactions of Alphagan and Colcrys, by gender? *:

female:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Abnormal behaviour
Bradycardia (abnormally slow heart action)
Drug ineffective
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

male:

Eye infection
Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
Muscle spasms (muscle contraction)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Back pain
Cardiac disorder
Cardiac failure congestive
Chronic kidney disease
Constipation

What are the common drug interactions of Alphagan and Colcrys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Fatigue (feeling of tiredness)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Muscle spasms (muscle contraction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Abnormal behaviour
Back pain

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 35.71%
High Blood Pressure: 5 people, 35.71%
Pain: 4 people, 28.57%
High Blood Cholesterol: 3 people, 21.43%
Thyroid Diseases: 2 people, 14.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 14.29%
Cough: 2 people, 14.29%
Diabetes: 2 people, 14.29%
Eye Infection: 2 people, 14.29%
Eye Pain: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan and Colcrys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously